These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 31114280)

  • 61. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of twelve single-drug regimens for the treatment of type 2 diabetes mellitus.
    Wang SL; Dong WB; Dong XL; Zhu WM; Wang FF; Han F; Yan X
    Oncotarget; 2017 Sep; 8(42):72700-72713. PubMed ID: 29069819
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Urinary metabolite signature in bipolar disorder patients during depressive episode.
    Chen JJ; Xie J; Zeng L; Zhou CJ; Zheng P; Xie P
    Aging (Albany NY); 2019 Feb; 11(3):1008-1018. PubMed ID: 30721880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders.
    Chen JJ; Bai SJ; Li WW; Zhou CJ; Zheng P; Fang L; Wang HY; Liu YY; Xie P
    Transl Psychiatry; 2018 Sep; 8(1):192. PubMed ID: 30232320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice.
    Kim SA; Lam TG; Yook JI; Ahn SG
    Aging (Albany NY); 2018 Sep; 10(9):2338-2355. PubMed ID: 30222592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age.
    Hou L; Wei X; Zhuo Y; Qin L; Yang F; Zhang L; Song X
    Aging (Albany NY); 2018 Sep; 10(9):2252-2265. PubMed ID: 30178754
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.
    Weiss R; Fernandez E; Liu Y; Strong R; Salmon AB
    Aging (Albany NY); 2018 Mar; 10(3):386-401. PubMed ID: 29579736
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials.
    Xie J; Deng W
    Neuropsychiatr Dis Treat; 2017; 13():2681-2690. PubMed ID: 29123401
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type 2 diabetes mellitus.
    DeFronzo RA; Ferrannini E; Groop L; Henry RR; Herman WH; Holst JJ; Hu FB; Kahn CR; Raz I; Shulman GI; Simonson DC; Testa MA; Weiss R
    Nat Rev Dis Primers; 2015 Jul; 1():15019. PubMed ID: 27189025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers.
    American Diabetes Association
    Clin Diabetes; 2016 Jan; 34(1):3-21. PubMed ID: 26807004
    [No Abstract]   [Full Text] [Related]  

  • 71. Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review.
    Kok JL; Williams A; Zhao L
    Int J Nurs Stud; 2015 Oct; 52(10):1625-39. PubMed ID: 26118440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 73. Interpretation of random effects meta-analyses.
    Riley RD; Higgins JP; Deeks JJ
    BMJ; 2011 Feb; 342():d549. PubMed ID: 21310794
    [No Abstract]   [Full Text] [Related]  

  • 74. Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus.
    Li Y; Xu L; Shen J; Ran J; Zhang Y; Wang M; Yan L; Cheng H; Fu Z
    Diabetes Res Clin Pract; 2010 Apr; 88(1):42-7. PubMed ID: 20060192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of the repaglinide efficiency in comparison to the glimepiride in the type 2 diabetes patients poorly regulated by the metmorfine administration.
    Dimic D; Velojic Golubovic M; Antic S; Radenkovic S
    Bratisl Lek Listy; 2009; 110(6):335-9. PubMed ID: 19634573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
    Nissen SE; Nicholls SJ; Wolski K; Nesto R; Kupfer S; Perez A; Jure H; De Larochellière R; Staniloae CS; Mavromatis K; Saw J; Hu B; Lincoff AM; Tuzcu EM;
    JAMA; 2008 Apr; 299(13):1561-73. PubMed ID: 18378631
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal.
    Fisher EB; Thorpe CT; Devellis BM; Devellis RF
    Diabetes Educ; 2007; 33(6):1080-103; discussion 1104-6. PubMed ID: 18057276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Measuring inconsistency in meta-analyses.
    Higgins JP; Thompson SG; Deeks JJ; Altman DG
    BMJ; 2003 Sep; 327(7414):557-60. PubMed ID: 12958120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.
    Derosa G; Mugellini A; Ciccarelli L; Crescenzi G; Fogari R
    Clin Ther; 2003 Feb; 25(2):472-84. PubMed ID: 12749508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.
    Culy CR; Jarvis B
    Drugs; 2001; 61(11):1625-60. PubMed ID: 11577798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.